Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

ConclusionsThe Japanese public intractable disease support system contributes to improvement of ADPKD treatment.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research